Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Dignitana AB (publ.)

Healthcare US DIZTF

NoneUSD
0.00(0%)

Last update at 2025-07-25T13:01:01.141304Z

Day Range

--
LowHigh

52 Week Range

0.200.46
LowHigh

Fundamentals

  • Previous Close -
  • Market Cap14.18M
  • VolumeNone
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-14.84400M
  • Revenue TTM85.47M
  • Revenue Per Share TTM1.22
  • Gross Profit TTM 46.38M
  • Diluted EPS TTM-0.03

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -22.39600M -43.07600M -52.96300M -37.95000M -25.84500M
Minority interest - - - - -
Net income -22.41100M -43.08600M -52.96300M -38.03500M -26.02100M
Selling general administrative - 30.05M 29.87M 34.98M 26.36M
Selling and marketing expenses - - - - -
Gross profit 46.38M 36.36M 29.71M 29.14M 29.66M
Reconciled depreciation 13.80M 12.72M 24.04M 10.27M 8.07M
Ebit -20.40300M -41.53300M -50.99800M -36.91900M -24.62200M
Ebitda -6.60400M -28.81000M -26.96200M -26.65200M -16.55500M
Depreciation and amortization 13.80M 12.72M 24.04M 10.27M 8.07M
Non operating income net other - - - - -
Operating income -20.61400M -41.55300M -50.70000M -36.52800M -24.02000M
Other operating expenses 103.04M 104.27M 100.47M 78.53M 57.87M
Interest expense 1.99M 1.53M 1.97M 1.03M 1.22M
Tax provision 0.01M 0.01000M 0.00000M 0.09M 0.18M
Interest income - 0.00000M 0.00100M 0.10M 0.00100M
Net interest income -1.99300M -1.52900M -1.96400M -0.92800M -1.22200M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.01M 0.01000M -0.29800M 0.09M 0.18M
Total revenue 73.00M 57.07M 46.63M 40.70M 33.74M
Total operating expenses 76.42M 83.56M 83.55M 66.97M 53.78M
Cost of revenue 26.62M 20.71M 16.92M 11.56M 4.08M
Total other income expense net -1.78200M -1.52300M -2.26300M -1.42200M -1.82500M
Discontinued operations - - - - -
Net income from continuing ops -22.41100M -43.08600M -52.96300M -38.03500M -26.02100M
Net income applicable to common shares -22.41100M -43.08600M -52.96300M -38.03500M -26.02100M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 58.55M 71.35M 137.89M 81.49M 80.37M
Intangible assets 7.14M 11.19M 16.23M 22.59M 19.03M
Earning assets - - - - -
Other current assets -0.00100M - - - -
Total liab 34.30M 40.17M 60.25M 26.39M 25.41M
Total stockholder equity 24.25M 31.19M 77.64M 55.10M 54.97M
Deferred long term liab 7.14M 11.19M 16.23M 22.59M 19.03M
Other current liab 10.27M 10.28M 37.28M 10.07M 7.13M
Common stock 7.05M 6.51M 6.51M 55.06M 48.60M
Capital stock 7.05M 6.51M 6.51M 55.06M 48.60M
Retained earnings -228.66300M -198.01200M -151.56200M -19.17400M -127.45200M
Other liab 0.19M 0.07M 0.02M 0.00001M -
Good will - - - - -
Other assets 7.31M 11.19M 16.23M 22.59M 19.03M
Cash 8.87M 14.50M 78.77M 19.43M 22.16M
Cash and equivalents - - - - -
Total current liabilities 25.50M 24.27M 58.57M 24.47M 22.48M
Current deferred revenue 8.36M 9.51M 13.54M 6.67M 4.80M
Net debt 9.40M 9.09M -69.14100M -12.01000M -11.97300M
Short term debt 9.65M 7.76M 7.97M 5.51M 7.26M
Short long term debt 9.65M 7.76M 7.97M 5.51M 7.26M
Short long term debt total 18.27M 23.59M 9.63M 7.42M 10.19M
Other stockholder equity 17.20M 24.68M 71.13M 19.22M 133.82M
Property plant equipment 27.17M 30.29M 27.50M 22.21M 14.75M
Total current assets 24.07M 29.87M 94.16M 36.68M 46.60M
Long term investments - - - - -
Net tangible assets 24.25M 31.19M 77.64M 55.10M 54.97M
Short term investments - - - - -
Net receivables 10.15M 6.03M 7.53M 7.33M 17.65M
Long term debt 8.61M 15.83M 1.66M 1.92M 2.93M
Inventory 5.05M 7.12M 7.46M 9.39M 6.31M
Accounts payable 5.58M 6.23M 13.33M 8.89M 8.09M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.18M - - 44.81M 33.78M
Deferred long term asset charges - - - - -
Non current assets total 34.48M 41.48M 43.73M 44.81M 33.78M
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -3.13000M -10.55600M -20.40400M -20.69900M -11.08800M
Change to liabilities 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Total cashflows from investing activities -3.05800M -10.55600M -20.40400M -20.69900M -11.08800M
Net borrowings -8.68500M -7.32100M 23.49M -2.76500M -5.68900M
Total cash from financing activities 15.03M -7.32100M 98.51M 45.16M 52.93M
Change to operating activities -1.01600M -12.96000M 7.34M 3.99M 3.97M
Net income -22.39600M -43.07600M -52.96300M -37.95000M -25.84500M
Change in cash -5.63200M -64.26900M 59.34M -2.72800M 21.14M
Begin period cash flow 14.50M 78.77M 19.43M 22.16M 1.02M
End period cash flow 8.87M 14.50M 78.77M 19.43M 22.16M
Total cash from operating activities -18.16400M -43.87300M -21.30300M -27.33400M -20.63200M
Issuance of capital stock 25.23M 0.00000M 75.19M 51.84M 66.54M
Depreciation 13.80M 12.72M 24.04M 10.27M 8.07M
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory 0.81M -0.46700M -1.50900M -3.08200M -3.46500M
Change to account receivables -1.68400M 0.42M -1.21400M 0.47M -3.31000M
Sale purchase of stock - - - - -
Other cashflows from financing activities -0.20300M 12.68M 23.32M -6.67100M -13.61700M
Change to netincome -7.73700M -0.51900M 7.52M -0.94000M 0.12M
Capital expenditures 3.22M 10.56M 20.40M 21.52M 11.09M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -1.88700M -13.00500M 4.62M 1.37M -2.80200M
Stock based compensation 0.14M 1.99M 1.84M - -
Other non cash items -7.82200M -2.50600M 1.17M -1.02500M -0.05200M
Free cash flow -21.38500M -54.42900M -41.70700M -48.85200M -31.72000M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
DIZTF
Dignitana AB (publ.)		 - -% - - - 0.17 9.26 0.17 -2.071
ABT
Abbott Laboratories		 -0.3402 0.38% 88.07 25.97 17.24 3.57 3.20 3.81 16.75
SYK
Stryker Corporation		 -3.305 1.07% 304.50 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC		 -0.0699 0.09% 79.27 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp		 -0.96 2.12% 44.33 31.49 17.24 4.41 3.65 4.88 19.19

Reports Covered

Stock Research & News

View All

Profile

Dignitana AB (publ), a medical technology company, develops, produces, and markets medical cooling devices in the United States and internationally. It offers DigniCap, a scalp cooling system used to reduce hair loss from certain chemotherapy treatments, as well as in the treats solid tumors from breast cancer. Dignitana AB (publ) was incorporated in 2007 is headquartered in Lund, Sweden.

Dignitana AB (publ.)

Traktorgränden 3, Lund, Sweden, 226 60

Key Executives

Name Title Year Born
Mr. William Cronin Deputy Chairman and Sr. Advisor of US Market & Reimbursement Strategies 1965
Mr. Christian Lindgren VP of Quality Affairs and Regulatory Affairs & Director 1974
Ms. Catarina Mård Löwenadler Chief Exec. Officer NA
Mr. Ulf Jonsson Chief Financial Officer NA
Mr. Johan Johansson VP of Operations, R&D NA
Ms. Melissa Bourestom Chief Communications Officer 1967
Mr. Cameron O'Mara Exec. VP of Worldwide Bus. Devel. & Sales 1979
Jane Wall Director of Clinical Services NA
Anette Cronstroem Exec. Officer NA
Thomas Joyce Exec. Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.